Dermatology NewsMost PsA patients discontinue initial biologic within 12 monthsApril 2, 2018Psoriatic Arthritis
Dermatology NewsStudy using U.K. data quantifies infection risk associated with psoriasisMarch 26, 2018PsoriasisPsoriatic ArthritisInfectious DiseasesPractice ManagementBusiness of Medicine
Dermatology NewsFDA approves certolizumab label update for pregnancy, breastfeedingMarch 22, 2018Psoriatic ArthritisPsoriasis
Dermatology NewsFDA approves IL-23 antagonist for plaque psoriasisMarch 22, 2018PsoriasisPsoriatic Arthritis
Dermatology NewsUltrasound study supports deep Koebner mechanism in PsA pathologyMarch 15, 2018Psoriatic Arthritis
Dermatology NewsPASI responses with biologics similar among white, nonwhite individuals, study findsMarch 12, 2018PsoriasisPsoriatic Arthritis
Dermatology NewsStudy highlights need to investigate psoriasis treatment outcomes in skin of color patientsMarch 9, 2018PsoriasisPsoriatic Arthritis
Dermatology NewsXeljanz: FDA panel recommends ulcerative colitis indicationMarch 8, 2018Psoriatic ArthritisPsoriasis
Dermatology NewsPsoriatic arthritis treatment: “We’re not doing so well”March 7, 2018Psoriatic Arthritis
Dermatology NewsVIDEO: PPACMAN aims to advance the combined rheum-derm clinic approach in the communityFebruary 27, 2018PsoriasisAutoimmune DiseasesPsoriatic Arthritis
Dermatology NewsCould guselkumab be a disease-modifying agent in plaque psoriasis?February 25, 2018PsoriasisPsoriatic Arthritis
Dermatology NewsUstekinumab quells aortic inflammation in patients with severe psoriasisFebruary 24, 2018PsoriasisPsoriatic Arthritis
Dermatology NewsBiologics have best chance of achieving PASI 90 in psoriasisFebruary 21, 2018PsoriasisPsoriatic Arthritis
